For the quarter ending 2025-09-30, CRBP has $109,514K in assets. $17,367K in debts. $26,983K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 26,983 | 20,044 | ||
| Investments | 76,999 | 96,548 | ||
| Restricted cash | 285 | 285 | ||
| Prepaid expenses and other current assets | 3,304 | 5,948 | ||
| Total current assets | 107,571 | 122,825 | ||
| Restricted cash | 385 | 385 | ||
| Property and equipment, gross | 4,458 | - | ||
| Less accumulated depreciation | 4,257 | - | ||
| Property and equipment, net | 201 | 251 | ||
| Operating lease right of use assets | 1,357 | 1,624 | ||
| Total assets | 109,514 | 125,085 | ||
| Accounts payable | 2,740 | 3,988 | ||
| Accrued expenses | 12,578 | 7,650 | ||
| Operating lease liabilities, current | 1,742 | 1,695 | ||
| Total current liabilities | 17,060 | 13,333 | ||
| Operating lease liabilities, noncurrent | 307 | 761 | ||
| Total liabilities | 17,367 | 14,094 | ||
| Common stock, 0.0001 par value 300,000,000 shares authorized, 12,534,853 and 12,179,482 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 1 | 1 | ||
| Additional paid-in capital | 627,024 | 622,562 | ||
| Accumulated deficit | -534,875 | -511,533 | ||
| Accumulated other comprehensive (loss) gain | -3 | -39 | ||
| Total stockholders equity | 92,147 | 110,991 | ||
| Total liabilities and stockholders equity | 109,514 | 125,085 | ||
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)